Oxidative stress induces apolipoprotein d overexpression in hippocampus during aging and alzheimer's disease

Journal of Alzheimer's Disease

Volumn 36, Issue 1, 2013, Pages 129-144

  Martínez, Eva ^a,b   Navarro, Ana ^a   Ordóñez, Cristina ^a   Del Valle, Eva ^a   Tolivia, Jorge ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Aging; Alzheimer's disease; apolipoprotein D; apoptosis; hippocampal cells; oxidative stress

Indexed keywords

APOLIPOPROTEIN D; HYDROGEN PEROXIDE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; BRAIN TISSUE; CELLULAR DISTRIBUTION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84878884842     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130215     Document Type: Article

References (98)

1. McConathy WJ, Alaupovic P (1973) Isolation and partial characterization of apolipoprotein D:Anewprotein moiety of the human plasma lipoprotein system. FEBS Lett 37, 178-182.
2. Vogt M, Skerra A (2001) Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J Mol Recognit 14, 79-86.
3. Eichinger A, Nasreen A, Kim HJ, Skerra A (2007) Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J Biol Chem 282, 31068-31075.
4. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R (2000) Apolipoprotein D. Biochim Biophys Acta 1482, 185-198.
5. Provost PR, Tremblay Y, el-Amine M, Belanger A (1995) Guinea pig apolipoprotein D RNA diversity, and developmental and gestational modulation of mRNA levels. Mol Cell Endocrinol 109, 225-236.
6. Seguin D, Desforges M, Rassart E (1995) Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Brain Res Mol Brain Res 30, 242-250.
7. Vieira AV, Lindstedt K, Schneider WJ,Vieira PM(1995) Identification of a circulatory and oocytic avian apolipoprotein D. Mol Reprod Dev 42, 443-446.
8. Sanchez D, Ganfornina MD, Martinez S (2002) Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech Dev 110, 225-229.
9. Ganfornina MD, Sanchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martinez S (2005) Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: Implications for the evolution of vertebrate lipocalins. Dev Dyn 232, 191-199.
10. Boyles JK, Notterpek LM, Anderson LJ (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem 265, 17805-17815.
11. Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, Olek K, Muller HW (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J 9, 2479-2484.
12. Ganfornina MD, Do Carmo S, Martinez E, Tolivia J, Navarro A, Rassart E, Sanchez D (2010) Apo D, an apolipoprotein expressed by Schwann cells, is required for peripheral nerve functional integrity and a timely response to injury. GLIA 58, 1320-1334.
13. Navarro A, Tolivia J, Astudillo A, delValle E (1998) Pattern of apolipoprotein D immunoreactivity in human brain. Neurosci Lett 254, 17-20.
14. Hu CY, Ong WY, Sundaram RK, Chan C, Patel SC (2001) Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. J Neurocytol 30, 209-218.
15. Navarro A, Del Valle E, Tolivia J (2004) Differential expression of apolipoprotein d in human astroglial and oligodendroglial cells. J Histochem Cytochem 52, 1031-1036.
16. Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG (2000) Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 22, 330-336.
17. Navarro A, Del Valle E, Juarez A, Martinez E, Ordoñez C, Astudillo A, Tolivia J (2010) Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan. Age (Dordr) 32, 85-96.
18. Ordoñez C, Navarro A, Perez C, Martinez E, Del Valle E, Tolivia J (2012) Gender differences in apolipoprotein D expression during aging and in Alzheimer disease. Neurobiol Aging 33, 433 e411-420.
19. Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, Wang J, Pan Y, Gabuzda DH, Li C, Prolla TA, Yankner BA (2008) Evolution of the aging brain transcriptome and synaptic regulation. PLoS ONE 3, e3329.
20. de Magalhaes JP, Curado J, Church GM(2009) Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 25, 875-881.
21. Muffat J,Walker DW(2010) Apolipoprotein D: An overview of its role in aging and age-related diseases. Cell Cycle 9, 269-273.
22. Montpied P, de Bock F, Lerner-Natoli M, Bockaert J, Rondouin G (1999) Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res 35, 135-146.
23. Terrisse L, Seguin D, Bertrand P, Poirier J, Milne R, Rassart E (1999) Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Brain Res Mol Brain Res 70, 26-35.
24. Do Carmo S, Jacomy H, Talbot PJ, Rassart E (2008) Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 28, 10330-10338.
25. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (2008) Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: Influence of enriched environment. J Cereb Blood Flow Metab 28, 551-562.
26. Thomas EA, Copolov DL, Sutcliffe JG (2003) From pharmacotherapy to pathophysiology: Emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr Mol Med 3, 408-418.
27. Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, Berger T (2001) Increased intrathecal production of apolipoprotein D in multiple sclerosis. J Neuroimmunol 119, 327-332.
28. Navarro A, Del Valle E, Astudillo A, Gonzalez del Rey C, Tolivia J (2003) Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol 184, 697-704.
29. Chen Y, Jia L,Wei C,Wang F, Lv H, Jia J (2008) Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res 1233, 196-202.
30. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI (2005) Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol Dis 20, 574-582.
31. del Valle E, Navarro A, Astudillo A, Tolivia J (2003) Apolipoprotein D expression in human brain reactive astrocytes. J Histochem Cytochem 51, 1285-1290.
32. Navarro A, Astudillo A, del Valle E, Gonzalez del Rey C, Tolivia J (2001) Immunohistochemical presence of apolipoprotein D in senile plaques. J Histotech 24, 45-48.
33. Simard J, de Launoit Y, Haagensen DE, Labrie F (1992) Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 130, 1115-1121.
34. Lopez-Boado YS, Klaus M, Dawson MI, Lopez-Otin C (1996) Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalphadependent signaling pathway. J Biol Chem 271, 32105-32111.
35. Martinez E, Navarro A, Ordoñez C, Del Valle E, Tolivia J (2012) Amyloid-beta25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells. J Alzheimers Dis 30, 233-244.
36. Do Carmo S, Seguin D, Milne R, Rassart E (2002) Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277, 5514-5523.
37. Do Carmo S, Levros LC, Jr., Rassart E (2007) Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 1773, 954-969.
38. Lambert J, Provost PR, Marcel YL, Rassart E (1993) Structure of the human apolipoproteinDgene promoter region. Biochim Biophys Acta 1172, 190-192.
39. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, Gonzalez C, Bastiani MJ, Rassart E, Sanchez D (2008) Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 7, 506-515.
40. Navarro A, Ordoñez C, Martinez E, Perez C, Astudillo A, Tolivia J (2008) Apolipoprotein D expression absence in degenerating neurons of human central nervous system. Histol Histopathol 23, 995-1001.
41. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, Ganfornina MD (2006) Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr Biol 16, 680-686.
42. Ruiz M, Sanchez D, Canal I, Acebes A, Ganfornina MD (2011) Sex-dependent modulation of longevity by two Drosophila homologues of human Apolipoprotein D, GLaz and NLaz. Exp Gerontol 46, 579-589.
43. Bajo-Graneras R, Sanchez D, Gutierrez G, Gonzalez C, Do Carmo S, Rassart E, Ganfornina MD (2011) Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J Neurochem 117, 949-960.
44. Bajo-Graneras R, Ganfornina MD, Martin-Tejedor E, Sanchez D (2011) Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquatchallenged dopaminergic systems. Glia 59, 1551-1566.
45. He X, Jittiwat J, Kim JH, Jenner AM, Farooqui AA, Patel SC, Ong WY (2009) Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainateinduced excitotoxic injury. Neurosci Lett 455, 183-186.
46. Kregel KC, Zhang HJ (2007) An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292, R18-R36.
47. Perez VI, Bokov A, Van Remmen H, Mele J, Ran Q, Ikeno Y, Richardson A (2009) Is the oxidative stress theory of aging dead? Biochim Biophys Acta 1790, 1005-1014.
48. Harman D (1956) Aging: A theory based on free radical and radiation chemistry. J Gerontol 11, 298-300.
49. Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA,Lee HG, Perry G (2010) Oxidative stress and its implications for future treatments and management of Alzheimer disease. Int J Biomed Sci 6, 225-227.
50. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci 18, 172-176.
51. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signalling in Alzheimer's disease. Brain Res 1000, 32-39.
52. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185.
53. Hardy J (2006) Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal. J Alzheimers Dis 9, 151-153.
54. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
55. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM(2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21, 4183-4187.
56. Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA(2007) Amyloid-beta in Alzheimer disease: The null versus the alternate hypotheses. J Pharmacol Exp Ther 321, 823-829.
57. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1, 45-55.
58. Perez C, Navarro A, Martinez E, Ordoñez C, Del Valle E, Tolivia J (2012) Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment. Age (Dordr) 34, 895-904.
59. Diez-Itza I, Vizoso F, Merino AM, Sanchez LM, Tolivia J, Fernandez J, Ruibal A, Lopez-Otin C (1994) Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol 144, 310-320.
60. Ordoñez C, Navarro A, Perez C, Astudillo A, Martinez E, Tolivia J (2006) Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 21, 361-366.
61. Tolivia J, Navarro A, Tolivia D (1994) Differential staining of nerve cells and fibres for sections of paraffin-embedded material in mammalian central nervous system. Histochemistry 102, 101-104.
62. Morimoto BH,Koshland DE, Jr. (1990) Induction and expression of long-and short-term neurosecretory potentiation in a neural cell line. Neuron 5, 875-880.
63. Teepker M, Anthes N, Krieg JC, Vedder H (2003) 2-OH-estradiol, an endogenous hormone with neuroprotective functions. J Psychiatr Res 37, 517-523.
64. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
65. Tolivia J, Navarro A, del Valle E, Perez C, Ordoñez C, Martinez E (2006) Application of Photoshop and Scion Image analysis to quantification of signals in histochemistry, immunocytochemistry and hybridocytochemistry. Anal Quant Cytol Histol 28, 43-53.
66. Andersen JK (2004) Oxidative stress in neurodegeneration: Cause or consequence? Nat Med 10 Suppl, S18-25.
67. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403.
68. Shankar SK (2010) Biology of aging brain. Indian J Pathol Microbiol 53, 595-604.
69. Glockner F, Ohm TG (2003) Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience 122, 103-110.
70. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664.
71. Catala A (2009) Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 157, 1-11.
72. Patel SC, Asotra K, Patel YC, McConathy WJ, Patel RC, Suresh S (1995) Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6, 653-657.
73. Xu Q, Konta T, Nakayama K, Furusu A, Moreno-Manzano V, Lucio-Cazana J, Ishikawa Y, Fine LG, Yao J, Kitamura M (2004) Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Free Radic Biol Med 36, 985-993.
74. Ishimura A, Ishige K, Taira T, Shimba S, Ono S, Ariga H, Tezuka M, Ito Y (2008) Comparative study of hydrogen peroxide-and 4-hydroxy-2-nonenal-induced cell death in HT22 cells. Neurochem Int 52, 776-785.
75. Coyle CH, Martinez LJ, Coleman MC, Spitz DR, Weintraub NL, Kader KN (2006) Mechanisms of H2O2-induced oxidative stress in endothelial cells. Free Radic Biol Med 40, 2206-2213.
76. Kaneko S,Kawakami S, HaraY,Wakamori M, Itoh E, Minami T, Takada Y, Kume T, Katsuki H, Mori Y, Akaike A (2006) A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci 101, 66-76.
77. Teepker M, Anthes N, Fischer S, Krieg JC, Vedder H (2007) Effects of oxidative challenge and calcium on ATP-levels in neuronal cells. Neurotoxicology 28, 19-26.
78. Chen X, Zhang Q, Cheng Q, Ding F (2009) Protective effect of salidroside against H2O2-induced cell apoptosis in primary culture of rat hippocampal neurons. Mol Cell Biochem 332, 85-93.
79. Lu WC, Chen CJ, Hsu HC, Hsu HL, Chen L (2010) The adaptor protein SH2B1beta reduces hydrogen peroxide-induced cell death in PC12 cells and hippocampal neurons. J Mol Signa 5, 17.
80. Gulden M, Jess A, Kammann J, Maser E, Seibert H (2010) Cytotoxic potency of H2O2 in cell cultures: Impact of cell concentration and exposure time. Free Radic Biol Med 49, 1298-1305.
81. Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222, 236-245.
82. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA(2010) Oxidative stress in Alzheimer disease:A possibility for prevention. Neuropharmacology 59, 290-294.
83. Belloir B, Kovari E, Surini-Demiri M, Savioz A (2001) Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 64, 61-69.
84. Castellani RJ, Lee HG, Zhu X, Nunomura A, Perry G, Smith MA (2006) Neuropathology of Alzheimer disease: Pathognomonic but not pathogenic. Acta Neuropathol 111, 503-509.
85. Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer's disease: The two-hit hypothesis. Lancet Neurol 3, 219-226.
86. Zhu X, Lee HG, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: An update. Biochim Biophys Acta 1772, 494-502.
87. Smith MA,Casadesus G, Joseph JA, Perry G(2002) Amyloidbeta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33, 1194-1199.
88. Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T (2007) Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry (Mosc) 46, 12737-12743.
89. Franz G, Reindl M, Patel SC, Beer R, Unterrichter I, Berger T, Schmutzhard E, Poewe W,Kampfl A(1999) Increased expression of apolipoprotein D following experimental traumatic brain injury. J Neurochem 73, 1615-1625.
90. Thomas EA, George RC, Danielson PE, Nelson PA, Warren AJ, Lo D, Sutcliffe JG (2003) Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolismrelated proteins. Mol Psychiatry 8, 983-993, 950.
91. Do Carmo S, Fournier D, Mounier C, Rassart E (2009) Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am J Physiol Endocrinol Metab 296, E802-E811.
92. Perdomo G, Dong HH (2009) Apolipoprotein D in Lipid Metabolism and Its Functional Implication in Atherosclerosis and Aging. Aging 1, 17-27.
93. Alvarez ML, Barbon JJ, Gonzalez LO, Abelairas J, Boto A, Vizoso FJ (2003) Apolipoprotein D expression in retinoblastoma. Ophthalmic Res 35, 111-116.
94. Muffat J, Walker DW, Benzer S (2008) Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc Natl Acad Sci U S A 105, 7088-7093.
95. Kim WS,Wong J,Weickert CS,Webster MJ, Bahn S, Garner B (2009) Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. J Neurochem 109, 1053-1066.
96. Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B (2011) Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: Implications for lipid antioxidant activity and Alzheimer's disease. Biochem J 442, 713-721.
97. Oakley AJ, Bhatia S, Ecroyd H, Garner B (2012) Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: Mechanism for selective oxidation of Met-93. PLoS One 7, e34057.
98. Zhang Y, Cong Y,Wang S, Zhang S (2010) Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D. Mol Biol Rep 38, 1847-1851.